Showing results (691-700 of 1,276) with videos related to
Sort By:
Pageof 128
American Heart Journal|June 7, 2011
Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routesPeter Wenaweser, Thomas Pilgrim, Nadja Roth, et al.JACC. Cardiovascular Interventions|October 28, 2025
Revascularization in Ischemic Left Ventricular Dysfunction: A Pathophysiology-Guided, Evidence-Based ApproachMatthew Ryan, Alexander G Truesdell, Gavin J Murphy, et al.Journal of the American Heart Association|March 17, 2016
Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE TrialRainer Zbinden, Raffaele Piccolo, Dik Heg, et al.American Heart Journal|June 20, 2017
Rationale and design of the Hunting for the off-target propertIes of Ticagrelor on Endothelial function and other Circulating biomarkers in Humans (HI-TECH) trialSara Ariotti, Maarten van Leeuwen, Salvatore Brugaletta, et al.JACC. Cardiovascular Interventions|August 9, 2020
Predictors of Outcomes Following Transcatheter Edge-to-Edge Mitral Valve RepairJeremy Ben-Shoshan, Pavel Overtchook, Jean Buithieu, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 1, 2018
Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trialYohei Sotomi, Yoshinobu Onuma, Shengnan Liu, et al.European Heart Journal|December 15, 2015
Prognostic value of PCSK9 levels in patients with acute coronary syndromesBaris Gencer, Fabrizio Montecucco, David Nanchen, et al.JACC. Cardiovascular Interventions|June 25, 2016
The Electrocardiogram After Transcatheter Aortic Valve Replacement Determines the Risk for Post-Procedural High-Degree AV Block and the Need for Telemetry MonitoringStefan Toggweiler, Stefan Stortecky, Erik Holy, et al.American Heart Journal|March 5, 2019
Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial)Dhanunjaya Lakkireddy, Stephan Windecker, David Thaler, et al.Atherosclerosis Plus|October 1, 2024
Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromesCédric Follonier, Gabriel Rabassa, Mattia Branca, et al.Pageof 128